Talya NevoHacohen - Sabra Healthcare President
| SBRA Stock | USD 16.42 0.54 3.40% |
President
Ms. Talya NevoHacohen is the Executive Vice President, Chief Investment Officer and Treasurer of the Company. She has served as Sabras Executive Vice President, Chief Investment Officer and Treasurer since November 2010. From September 2006 to August 2008 and from February 2009 to November 2010, Ms. NevoHacohen served as an advisor to private real estate developers and operators regarding property acquisitions and dispositions, corporate capitalization, and equity and debt capital raising. From August 2008 to February 2009, Ms. NevoHacohen was a Managing Director with Cerberus Real Estate Capital Management, LLC, an affiliate of Cerberus Capital Management, L.P., a private investment firm. From 2003 to 2006, Ms. NevoHacohen served as Senior Vice PresidentCapital Markets and Treasurer for HCP, Inc., a healthcare REIT. Previously, from 1993 to 2003, Ms. NevoHacohen worked for Goldman, Sachs Co. where she was a Vice President in the investment banking and finance, operations and administration divisions. Prior to her affiliation with Goldman Sachs, she practiced architecture and was associated with several architectural firms in New York. since 2010.
| Age | 65 |
| Tenure | 15 years |
| Address | 1781 Flight Way, Tustin, CA, United States, 92782-0539 |
| Phone | 888 393 8248 |
| Web | https://www.sabrahealth.com |
Sabra Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.03 % which means that it generated a profit of $0.03 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0457 %, meaning that it created $0.0457 on every $100 dollars invested by stockholders. Sabra Healthcare's management efficiency ratios could be used to measure how well Sabra Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.05, whereas Return On Tangible Assets are forecasted to decline to 0.02. At present, Sabra Healthcare's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 6.2 M, whereas Total Assets are forecasted to decline to about 4.3 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Daniel Klein | Healthpeak Properties | 56 | |
| Bradley Page | Healthpeak Properties | 60 | |
| Robert Hull | Healthcare Realty Trust | 53 | |
| Emmett McLean | Medical Properties Trust | 69 | |
| Leigh Stach | Community Healthcare Trust | 58 | |
| Allen Webb | Global Medical REIT | 50 | |
| Matthew McQueen | Welltower | 47 | |
| John Burkart | Welltower | 61 | |
| Steven Hamner | Medical Properties Trust | 63 | |
| Clint Malin | LTC Properties | 52 | |
| Timothy CFA | Welltower | 39 | |
| Mark Theine | Healthpeak Properties | 41 | |
| Del Taylor | Healthpeak Properties | 67 | |
| Cheryl Ramagano | Universal Health Realty | 62 | |
| J Douglas | Healthcare Realty Trust | 45 | |
| Mandi Hogan | LTC Properties | N/A | |
| Caroline Chikhale | LTC Properties | 47 | |
| John Bryant | Healthcare Realty Trust | 58 | |
| Jeffrey Theiler | Healthpeak Properties | 50 | |
| Laurie Becker | Healthpeak Properties | 44 | |
| D Mendelsohn | National Health Investors | 59 | |
Management Performance
| Return On Equity | 0.0457 | ||||
| Return On Asset | 0.03 |
Sabra Healthcare REIT Leadership Team
Elected by the shareholders, the Sabra Healthcare's board of directors comprises two types of representatives: Sabra Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sabra. The board's role is to monitor Sabra Healthcare's management team and ensure that shareholders' interests are well served. Sabra Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sabra Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Nyland, Executive Management | ||
| Talya NevoHacohen, Executive Vice President Chief Investment Officer, Treasurer | ||
| Michael Costa, CFO VP | ||
| Eliza Gozar, Senior Investments | ||
| Michael CPA, CFO VP | ||
| Kara Pappanduros, Senior Management | ||
| Darrin Smith, Executive Investments | ||
| Jessica Flores, Chief VP | ||
| Harold Andrews, CFO, Executive VP, Secretary and Controller | ||
| Lukas CFA, Executive Finance | ||
| Richard Matros, Chairman, CEO and Pres |
Sabra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sabra Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0457 | ||||
| Return On Asset | 0.03 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.37 % | ||||
| Current Valuation | 6.16 B | ||||
| Shares Outstanding | 237.91 M | ||||
| Shares Owned By Insiders | 1.31 % | ||||
| Shares Owned By Institutions | 98.69 % | ||||
| Number Of Shares Shorted | 17.72 M | ||||
| Price To Earning | 67.37 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.827 | Dividend Share 1.2 | Earnings Share 0.54 | Revenue Per Share | Quarterly Revenue Growth 0.125 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.